Want to see HK:0546 full AI Analyst Report?
Fufeng Group Limited (0546) Price & Analysis
0546 Stock Chart & Stats
- Day’s Range
- HKD 3.92 - HKD 4.00
- 52-Week Range
- HKD 3.82 - HKD 9.49
- Previous Close
- HKD 3.98
- Volume
- 3.61M
- Average Volume (3M)
- 5.80M
- Market Cap
- HKD 9.98B
- Enterprise Value
- HKD 11.88B
- Total Cash (Recent Filing)
- HKD 21.53B
- Total Debt (Recent Filing)
- HKD 21.55B
- Price to Earnings (P/E)
- 0.2
- Beta
- 0.64
- Next Earnings
- Mar 31, 2027
- EPS Estimate
- 0.24
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 4.10%
Bulls Say, Bears Say
Bulls Say
Diversified Bio-fermentation And Corn-processing Platform
The company serves multiple end markets with a broad portfolio of fermentation and corn-processing ingredients. This product and customer diversification can support recurring industrial demand, reduce reliance on one application, and provide flexibility to shift mix toward higher-value products over the next several quarters.
Positive Operating Cash Generation
Positive and fairly steady operating cash generation indicates that the core business is still converting ongoing operations into cash despite weaker recent earnings conditions. That provides an internal funding base for operations and can support resilience while profitability and product pricing remain under pressure.
Still-profitable Operations And Meaningful Equity Support
The company remains profitable with a solid 2025 net margin, and equity provides a meaningful base for the balance sheet. Continued earnings capacity gives management resources to operate through a softer cycle, while the equity cushion offers some protection against business volatility.
Bears Say
Recent Revenue Contraction And Margin Compression
The combination of consecutive recent revenue softness and lower gross, operating, and EBITDA margins points to a less favorable earnings environment. If this persists, weaker pricing or cost spreads could reduce profitability, limit reinvestment capacity, and make earnings more dependent on volume and mix.
Higher Leverage Reduces Financial Flexibility
The sharp increase in debt relative to equity raises the company’s fixed financial burden and reduces room to respond to prolonged margin weakness. Higher leverage can constrain capital allocation, make balance-sheet repair more important, and increase vulnerability if operating performance deteriorates further.
Weak And Volatile Free-cash-flow Conversion
Near-breakeven free cash flow despite continued reported profitability signals that earnings are not consistently translating into discretionary cash. Historical negative periods and recent deterioration may limit debt reduction, dividends, or growth investment, making cash conversion a durable monitoring concern.
Fufeng Group Limited News
0546 FAQ
What was Fufeng Group Limited’s price range in the past 12 months?
What is Fufeng Group Limited’s market cap?
When is Fufeng Group Limited’s upcoming earnings report date?
How were Fufeng Group Limited’s earnings last quarter?
Is Fufeng Group Limited overvalued?
Does Fufeng Group Limited pay dividends?
What is Fufeng Group Limited’s EPS estimate?
How many shares outstanding does Fufeng Group Limited have?
What happened to Fufeng Group Limited’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Fufeng Group Limited?
What is the TipRanks Smart Score and how is it calculated?
Fufeng Group Limited Stock Smart Score
Company Description
Fufeng Group Limited
Fufeng Group Limited, an investment holding company, specializes in the global production and distribution of fermentation-based food additives, biochemicals, and starch-derived products, operating across markets in the People's Republic of China and internationally. Its business is structured into several key segments: Food Additives, Animal Nutrition, High-End Amino Acid, Colloid, and an encompassing 'Other' segment. The Food Additives division is responsible for manufacturing and selling items such as monosodium glutamate (MSG), starch sweeteners, glutamic acid, compound seasonings, and corn oil. The Animal Nutrition segment focuses on producing and selling refined corn products, threonine, and lysine. High-end amino acids are offered through its dedicated segment, while the Colloid segment provides specialty gums like xanthan and gellan gum. The 'Other' segment encompasses a diverse range of products, including fertilizers, synthetic ammonia, and pharmaceuticals. Beyond these core activities, Fufeng Group is also engaged in the manufacturing and sale of construction materials such as autoclaved aerated concrete blocks and bricks, alongside eubacteria material medicine and various preparations. The company actively invests in the research, development, promotion, and industrialization of innovative biological techniques and their resultant achievements. Furthermore, it deals in cosmetics, biological products, and health foods, while also offering logistics, equity investment, and biological technique information services. Fufeng Group Limited was founded in 1999 and is headquartered in Linyi, People's Republic of China.
- Sector
- Basicmaterials
- Industry
- Chemicals - Specialty
- CEO
- Deheng Li
- Employees
- 17,000
- Website
- www.fufeng-group.com
- Address
- Building 4, Qingdao, SD, 266114, CN
Fufeng Group Limited (0546) Earnings & Revenues
0546 Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 5 | 13 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 1 | 0 | 11 |








